Hosaka Fumitaka, Shiga Tsuyoshi, Sakomura Yasunari, Wakaumi Michi, Matsuda Naoki, Kasanuki Hiroshi
Department of Cardiology, The Heart Institute of Japan, Tokyo Women's Medical University, Japan
Heart Vessels. 2002 May;16(4):154-6. doi: 10.1007/s003800200012.
The tissue distribution of amiodarone and desethylamiodarone, its active metabolite, was examined in an autopsied case, an 85-year-old man, with arrhythmogenic right ventricular cardiomyopathy (ARVC) who had been receiving amiodarone for 4 years. High concentrations of amiodarone, a very highly lipophilic compound, were found in adipose and bone marrow tissues. Despite a low dose (100 mg daily), the concentrations of amiodarone were higher in the epicardial fat (570.4 microg/g) and in the right atrium (165.3 microg/g) than previously reported in patients with other cardiac diseases. The ratios of amiodarone/ desethylamiodarone concentrations in both tissues were >1. This unique distribution demonstrates the involvement of histological characteristics of ARVC, such as fatty replacement of myocardium. We anticipate that a low dose of amiodarone would be effective in preventing arrhythmia in some patients with ARVC.
在一例尸检病例中,对胺碘酮及其活性代谢产物去乙基胺碘酮的组织分布进行了研究。该病例为一名85岁男性,患有致心律失常性右室心肌病(ARVC),已接受胺碘酮治疗4年。胺碘酮是一种脂溶性非常高的化合物,在脂肪组织和骨髓组织中发现了高浓度的胺碘酮。尽管剂量较低(每日100毫克),但胺碘酮在心外膜脂肪(570.4微克/克)和右心房(165.3微克/克)中的浓度高于先前报道的其他心脏病患者。两种组织中胺碘酮/去乙基胺碘酮浓度之比均>1。这种独特的分布表明ARVC的组织学特征参与其中,如心肌的脂肪替代。我们预计低剂量的胺碘酮对预防某些ARVC患者的心律失常有效。